
Neuropad® detecta daños ocultos en el sistema nervioso autónomo en pacientes colombianos con diabetes tipo 2.

The article titled «Neuropad® for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes» (Mendivil et al., 2016) discusses the prevalence and impact of cardiovascular autonomic neuropathy (CAN) in patients with type 2 diabetes. The authors evaluate…









